The ARG tyrosine kinase is inhibited by STI571.

被引：0
|
作者：
Okuda, K
Weisberg, E
Gilliland, DG
Griffin, JD
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1487
引用
收藏
页码：344A / 344A
页数：1
相关论文
共 50 条
  • [31] The selective tyrosine kinase inhibitor STI571 inhibits small cell lung cancer growth
    Krystal, GW
    Honsawek, S
    Litz, J
    Buchdunger, E
    CLINICAL CANCER RESEARCH, 2000, 6 (08) : 3319 - 3326
  • [32] Tyrosine kinase inhibitor STI-571/Gleevec down-regulates the β-catenin signaling activity
    Zhou, L
    An, NL
    Haydon, RC
    Zhou, QX
    Cheng, HW
    Peng, Y
    Jiang, W
    Luu, HH
    Vanichakarn, P
    Szatkowski, JP
    Park, JY
    Breyer, B
    He, TC
    CANCER LETTERS, 2003, 193 (02) : 161 - 170
  • [33] A point mutation in the ABL catalytic domain induces resistance to the tyrosine kinase inhibitor STI 571.
    Roumiantsev, S
    Brasher, BB
    Van Etten, RA
    BLOOD, 2000, 96 (11) : 470A - 470A
  • [34] Mice with a CML-like disease relapse with an acute lymphocytic leukemia after treatment with STI571.
    Miething, C
    Grundler, R
    Hoepfl, J
    Mugler, C
    Peschel, C
    Duyster, J
    BLOOD, 2001, 98 (11) : 714A - 715A
  • [35] Growth inhibition of rat osteosarcoma and malignant fibrous histiocytoma cells by tyrosine kinase inhibitor STI571
    Yoshitani, K
    Honoki, K
    Morishita, T
    Kido, A
    Miyauchi, Y
    Mii, Y
    Takakura, Y
    IN VIVO, 2003, 17 (03): : 255 - 258
  • [36] Inhibition of cell survival and invasive potential of colorectal carcinoma cells by the tyrosine kinase inhibitor STI571
    Bellone, G
    Ferrero, D
    Carbone, A
    De Quadros, MR
    Gramigni, C
    Prati, A
    Davidson, W
    Mioli, P
    Dughera, L
    Emanuelli, G
    Rodeck, U
    CANCER BIOLOGY & THERAPY, 2004, 3 (04) : 385 - 392
  • [37] The tyrosine kinase inhibitor STI571 induces cellular clearance of PrPSc in prion-infected cells
    Ertmer, A
    Gilch, S
    Yun, SW
    Flechsig, E
    Klebl, B
    Stein-Gerlach, M
    Klein, MA
    Schätzl, HM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (40) : 41918 - 41927
  • [38] ONIOM DFT/PM3 calculation on the interaction between STI-571 and abelson tyrosine kinase
    Yuan-Zhen Xiong
    Pei-Yu Chen
    Journal of Molecular Modeling, 2008, 14 : 1083 - 1086
  • [39] In vitro cytotoxic effects of a tyrosine kinase inhibitor STI571 in combination with commonly used antileukemic agents
    Kano, Y
    Akutsu, M
    Tsunoda, S
    Mano, H
    Sato, Y
    Honma, Y
    Furukawa, Y
    BLOOD, 2001, 97 (07) : 1999 - 2007
  • [40] Effects of the tyrosine-kinase inhibitor STI571 on mutated KIT and neoplastic mast cells.
    Akin, C
    Longley, BJ
    Brockow, K
    Metcalfe, DD
    BLOOD, 2000, 96 (11) : 747A - 747A
12345